Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Kirby

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Pharmaceutics|April 30, 2021
Stereolithography Apparatus Evolution: Enhancing Throughput and Efficiency of Pharmaceutical Formulation DevelopmentCarlo Curti, Daniel J Kirby, Craig A Russell
International Journal of Pharmaceutics|February 2, 2024
Systematic screening of photopolymer resins for stereolithography (SLA) 3D printing of solid oral dosage forms: Investigation of formulation factors on printability outcomesCarlo Curti, Daniel J Kirby, Craig A Russell
Therapeutic Delivery|July 27, 2012
Formulation design considerations for oral vaccinesJitinder Wilkhu, Sarah E McNeil, Daniel J Kirby, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 29, 2011
Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responsesRandip Kaur, Vincent W Bramwell, Daniel J Kirby, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2012
Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell responseRandip Kaur, Vincent W Bramwell, Daniel J Kirby, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 13, 2017
Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettabilityNikhila Miriyala, Defang Ouyang, Yvonne Perrie, et al.
The Journal of Pharmacy and Pharmacology|November 3, 2010
Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agentM Habib Ali, Daniel J Kirby, Afzal R Mohammed, et al.
International Journal of Pharmaceutics|July 7, 2012
The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugsM Habib Ali, Behfar Moghaddam, Daniel J Kirby, et al.
BMJ Paediatrics Open|December 11, 2020
Literature review of medication administration problems in paediatrics by parent/caregiver and the role of health literacyDania Talaat Dahmash, Zakia B Shariff, Daniel J Kirby, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 2, 2010
Increased potential of a cationic liposome-based delivery system: enhancing stability and sustained immunological activity in pre-clinical developmentAfzal R Mohammed, Vincent W Bramwell, Daniel J Kirby, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmaceutics|April 30, 2021
Stereolithography Apparatus Evolution: Enhancing Throughput and Efficiency of Pharmaceutical Formulation DevelopmentCarlo Curti, Daniel J Kirby, Craig A Russell
International Journal of Pharmaceutics|February 2, 2024
Systematic screening of photopolymer resins for stereolithography (SLA) 3D printing of solid oral dosage forms: Investigation of formulation factors on printability outcomesCarlo Curti, Daniel J Kirby, Craig A Russell
Therapeutic Delivery|July 27, 2012
Formulation design considerations for oral vaccinesJitinder Wilkhu, Sarah E McNeil, Daniel J Kirby, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 29, 2011
Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responsesRandip Kaur, Vincent W Bramwell, Daniel J Kirby, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2012
Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell responseRandip Kaur, Vincent W Bramwell, Daniel J Kirby, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 13, 2017
Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettabilityNikhila Miriyala, Defang Ouyang, Yvonne Perrie, et al.
The Journal of Pharmacy and Pharmacology|November 3, 2010
Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agentM Habib Ali, Daniel J Kirby, Afzal R Mohammed, et al.
International Journal of Pharmaceutics|July 7, 2012
The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugsM Habib Ali, Behfar Moghaddam, Daniel J Kirby, et al.
BMJ Paediatrics Open|December 11, 2020
Literature review of medication administration problems in paediatrics by parent/caregiver and the role of health literacyDania Talaat Dahmash, Zakia B Shariff, Daniel J Kirby, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 2, 2010
Increased potential of a cationic liposome-based delivery system: enhancing stability and sustained immunological activity in pre-clinical developmentAfzal R Mohammed, Vincent W Bramwell, Daniel J Kirby, et al.
Pageof 3